Emplicure's CEO presents the company on two occasions in March

Monday March 14, 2022, at 12:00 - Aktiedagen Stockholm
The presentationen can be streamed live or on demand via the Aktiespararna YouTube-channel or aktiespararna.se/tv/live.

Questions during the live stream can be asked via text message to +46 79-347 98 45 or via email to [email protected]

Wednesday March 16, 2022 at 11:45 - BioStock Investor Meeting
The presentationen can be streamed live or on demand via the BioStock YouTube-channel
or via BioStock Investor Meeting

For more information, please contact:

Torbjörn W. Larsson
VD
Phone: +46 (0)70 747 65 99
Email: [email protected]

Erik Magnusson
CFO, Investor Relations
Phone: +46 (0)708 565 245
Email: [email protected]

Certified Adviser
Mangold Fondkommission AB
Phone: +46 (0)8 5030 1550, or [email protected]

The following documents can be retrieved from beQuoted
PM-Emplicures-CEO-presents-the-company-on-two-occasions.pdf

Emplicure is a pharmaceutical company developing new and innovative drugs by combining existing and approved active substances, and advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain, and with abuse deterrent formulations. The wholly owned subisidiary, Amplicon AB develops consumer products, with tobacco-free nicotine as the first product. Read more at www.emplicure.com

If you want to open the text in your webbrowser click here
______________________________________________________
This information was sent by beQuoted
If you want more information, please go to www.beQuoted.com
To change your subscription, please inform [email protected]

beQuoted Press är en service till Dig som är intresserad av finansiell information. Med beQuoted Press underlättas företagens finansiella kommunikation till Dig och till nyhetsbyråer, aktieägare, placeringsrådgivare och andra intressenter på aktiemarknaden.

Vi hoppas att Du uppskattar denna service.